Regulatory T cells require the phosphatase PTEN to maintain suppressive function in homeostatic conditions through preserved expression of CD25 and the transcription factor Foxp3.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The new progress in cancer immunotherapy
Clinical and Experimental Medicine Open Access 15 September 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Josefowicz, S.Z., Lu, L.-F. & Rudensky, A.Y. Annu. Rev. Immunol. 30, 531–564 (2012).
Huynh, A. et al. Nat. Immunol. 16, 188–196 (2015).
Shrestha, S. et al. Nat. Immunol. 16, 178–187 (2015).
Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R. & Farrar, M.A. J. Immunol. 178, 280–290 (2007).
Powell, J.D., Pollizzi, K.N., Heikamp, E.B. & Horton, M.R. Annu. Rev. Immunol. 30, 39–68 (2012).
Michalek, R.D. et al. J. Immunol. 186, 3299–3303 (2011).
Liu, X. et al. J. Clin. Invest. 120, 2497–2507 (2010).
Walsh, P.T. et al. J. Clin. Invest. 116, 2521–2531 (2006).
Bailey-Bucktrout, S.L. et al. Immunity 39, 949–962 (2013).
Lee, S.K. et al. Immunity 37, 880–892 (2012).
Johnston, R.J., Choi, Y.S., Diamond, J.A., Yang, J.A. & Crotty, S. J. Exp. Med. 209, 243–250 (2012).
Kato, H. & Perl, A. J. Immunol. 192, 4134–4144 (2014).
Scalapino, K.J. & Daikh, D.I. PLoS ONE 4, e6031 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ray, J., Craft, J. PTENtiating autoimmunity through Treg cell deregulation. Nat Immunol 16, 139–140 (2015). https://doi.org/10.1038/ni.3082
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3082
This article is cited by
-
The new progress in cancer immunotherapy
Clinical and Experimental Medicine (2022)
-
The functions of tumor suppressor PTEN in innate and adaptive immunity
Cellular & Molecular Immunology (2017)
-
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Nature Reviews Rheumatology (2016)